alpha-Synuclein and intracellular trafficking: impact on the spreading of Parkinson's disease pathology

被引:51
|
作者
Eisbach, Sibylle E. [1 ]
Outeiro, Tiago F. [1 ]
机构
[1] Univ Med Ctr Gottingen, Ctr Nanoscale Microscopy & Mol Physiol Brain, Dept Neurodegenerat & Restorat Res, D-37073 Gottingen, Germany
来源
JOURNAL OF MOLECULAR MEDICINE-JMM | 2013年 / 91卷 / 06期
关键词
alpha-Synuclein; Trafficking; Spreading; Prion; Transmission; Parkinson's disease; TO-NEURON TRANSMISSION; N-TERMINAL ACETYLATION; SUBSTANTIA-NIGRA; RAB GTPASES; SYNAPTIC DYSFUNCTION; AXONAL-TRANSPORT; IRON CONTENT; CELL-DEATH; IN-VITRO; MEMBRANE;
D O I
10.1007/s00109-013-1038-9
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Parkinson's disease is characterized by intracellular proteinaceous depositions known as Lewy bodies. These largely consist of the protein alpha-synuclein, whose physiological function remains unclear, but mutations and overexpression of the protein have been shown to cause early onset cases of Parkinson's disease. Deregulation of alpha-synuclein biology causes neurodegeneration and impaired neuronal trafficking, hinting at a possible contribution to the pathological mechanism. Recent studies produced some evidence hinting at the involvement of several regulators of the transport machinery such as Rab GTPases and SNARE proteins, but also shown that alpha-synuclein can be propagated between cells. Here, we discuss the molecular interplay of alpha-synuclein with the intracellular transport machinery, its consequences, and the implications for disease mechanisms.
引用
收藏
页码:693 / 703
页数:11
相关论文
共 50 条
  • [1] alpha-Synuclein and intracellular trafficking: impact on the spreading of Parkinson’s disease pathology
    Sibylle E. Eisbach
    Tiago F. Outeiro
    Journal of Molecular Medicine, 2013, 91 : 693 - 703
  • [2] Alpha-synuclein spreading in Parkinson's disease
    Recasens, Ariadna
    Dehay, Benjamin
    FRONTIERS IN NEUROANATOMY, 2014, 8
  • [3] Alpha-synuclein and the prion hypothesis in Parkinson's disease
    Melki, R.
    REVUE NEUROLOGIQUE, 2018, 174 (09) : 644 - 652
  • [4] Alpha-Synuclein Targeting Therapeutics for Parkinson's Disease and Related Synucleinopathies
    Menon, Sindhu
    Armstrong, Sabrina
    Hamzeh, Amir
    Visanji, Naomi P.
    Sardi, Sergio Pablo
    Tandon, Anurag
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [5] Where and how alpha-synuclein pathology spreads in Parkinson's disease
    Wakabayashi, Koichi
    NEUROPATHOLOGY, 2020, 40 (05) : 415 - 425
  • [6] Features of alpha-synuclein that could explain the progression and irreversibility of Parkinson's disease
    Gallegos, Scarlet
    Pacheco, Carla
    Peters, Christian
    Opazo, Carlos M.
    Aguayo, Luis G.
    FRONTIERS IN NEUROSCIENCE, 2015, 9
  • [7] Alpha-Synuclein Pathology and the Role of the Microbiota in Parkinson's Disease
    Fitzgerald, Emily
    Murphy, Sarah
    Martinson, Holly A.
    FRONTIERS IN NEUROSCIENCE, 2019, 13
  • [8] Targeting Alpha-Synuclein as a Therapy for Parkinson's Disease
    Fields, Carroll Rutherford
    Bengoa-Vergniory, Nora
    Wade-Martins, Richard
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2019, 12
  • [9] Alpha-Synuclein: The Interplay of Pathology, Neuroinflammation, and Environmental Factors in Parkinson's Disease
    He, Songzhe
    Zhong, Shan
    Liu, Gang
    Yang, Jun
    NEURODEGENERATIVE DISEASES, 2021, 20 (2-3) : 55 - 64
  • [10] Alpha-synuclein, lipids and Parkinson's disease
    Ruiperez, Violeta
    Darios, Frederic
    Davletov, Bazbek
    PROGRESS IN LIPID RESEARCH, 2010, 49 (04) : 420 - 428